UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 170

Sortiert nach

Quantitative muscle ultrasound: a potential tool for assessment of disease activity in juvenile dermatomyositis

Scandinavian journal of rheumatology, 2014-01, Vol.43 (4), p.339-341

2014

Link zum Volltext

Verfügbarkeit prüfen

The Disease Activity Score and the EULAR response criteria

Clinical and experimental rheumatology, 2005-09, Vol.23 (5 Suppl 39), p.S93

2005

Link zum Volltext

Verfügbarkeit prüfen

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Annals of the rheumatic diseases, 2011-09, Vol.70 (9), p.1575-1580

2011

Link zum Volltext

Verfügbarkeit prüfen

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

Rheumatology (Oxford, England), 2004-10, Vol.43 (10), p.1252-1255

2004

Link zum Volltext

Verfügbarkeit prüfen

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

Annals of the rheumatic diseases, 2005-01, Vol.64 (1), p.127-129

2005

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Arthritis research & therapy, 2016-02, Vol.18 (50), p.50-50, Article 50

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

Annals of the rheumatic diseases, 2004-05, Vol.63 (5), p.508-516

2004

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.374-377

2012

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial

Annals of the rheumatic diseases, 2005-09, Vol.64 (9), p.1294-1298

2005

Link zum Volltext

Verfügbarkeit prüfen

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.303-305

2005

Link zum Volltext

Verfügbarkeit prüfen

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study

Arthritis research & therapy, 2005, Vol.7 (3), p.R666-R676

2005

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based tailored conservative treatment of knee and hip osteoarthritis: between knowing and doing

Scandinavian journal of rheumatology, 2011-05, Vol.40 (3), p.225-231

2011

Link zum Volltext

Verfügbarkeit prüfen

Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial

Pain (Amsterdam), 2002-11, Vol.100 (1), p.141-153

2002

Link zum Volltext

Verfügbarkeit prüfen

AB1028 Development and Validation of A Patient Questionnaire on Rheumatoid Arthritis Disease Related Knowledge in The Treat To Target Era: Preliminary Results

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1253-1253

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Annals of the rheumatic diseases, 2003-12, Vol.62 (12), p.1168-1177

2003

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate modulates the kinetics of adenosine in humans in vivo

Annals of the rheumatic diseases, 2006-04, Vol.65 (4), p.465-470

2006

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Arthritis research & therapy, 2016-06, Vol.18 (1), p.144-144, Article 144

2016

Link zum Volltext

Verfügbarkeit prüfen

A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis

Journal of rheumatology, 2002-11, Vol.29 (11), p.2288

2002

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of the cervical spine with conventional radiographs in patients with rheumatoid arthritis

Scandinavian journal of rheumatology, 2013-01, Vol.42 (4), p.281-288

2013

Link zum Volltext

Verfügbarkeit prüfen

Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses

Arthritis research & therapy, 2010-01, Vol.12 (3), p.R89-R89

2010

Link zum Volltext

Verfügbarkeit prüfen

Long term anti-tumour necrosis factor α monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation

Annals of the rheumatic diseases, 2002-04, Vol.61 (4), p.311-318

2002

Link zum Volltext

Verfügbarkeit prüfen

Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis

Annals of the rheumatic diseases, 2003-11, Vol.62 (suppl 2), p.ii30-ii33

2003

Link zum Volltext

Verfügbarkeit prüfen

The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients

Scandinavian journal of rheumatology, 2013-01, Vol.42 (1), p.15-19

2013

Link zum Volltext

Verfügbarkeit prüfen

AB1435-HPR The contribution of assessing foot joints in early rheumatoid arthritis patients: Insights from item response theory

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.757-757

2013

Link zum Volltext

Verfügbarkeit prüfen

Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis

Scandinavian journal of rheumatology, 2011-05, Vol.40 (3), p.192-196

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(167)
Tagungsberichte
(3)

Sprache

Englisch
(170)
Japanisch
(10)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(155)
Science & Technology
(155)
Humans
(150)
Rheumatology
(134)
Biological And Medical Sciences
(94)
Medical Sciences
(92)
Female
(89)
Male
(86)
Middle Aged
(80)
Arthritis, Rheumatoid - Drug Therapy
(77)
Rheumatoid Arthritis
(72)
Adult
(59)
Aged
(58)
Diseases Of The Osteoarticular System
(57)
Inflammatory Joint Diseases
(52)
Antirheumatic Agents - Therapeutic Use
(39)
Severity Of Illness Index
(38)
Treatment Outcome
(37)
Arthritis, Rheumatoid - Physiopathology
(30)
Pharmacology. Drug Treatments
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative muscle ultrasound: a potential tool for assessment of disease activity in juvenile dermatomyositis

The Disease Activity Score and the EULAR response criteria

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study

Evidence-based tailored conservative treatment of knee and hip osteoarthritis: between knowing and doing

Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial

AB1028 Development and Validation of A Patient Questionnaire on Rheumatoid Arthritis Disease Related Knowledge in The Treat To Target Era: Preliminary Results

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Methotrexate modulates the kinetics of adenosine in humans in vivo

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis

Long-term follow-up of the cervical spine with conventional radiographs in patients with rheumatoid arthritis

Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses

Long term anti-tumour necrosis factor α monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation

Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis

The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients

AB1435-HPR The contribution of assessing foot joints in early rheumatoid arthritis patients: Insights from item response theory

Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis

Suchergebnisse filtern